The Genotype of Early-Transmitting HIV gp120s Promotes αβ –Reactivity, Revealing αβ/CD4 T cells As Key Targets in Mucosal Transmission

English version České info

Mucosal transmission of HIV is inefficient. The virus must breach physical barriers before it infects mucosal CD4⁺ T cells. Low-level viral replication occurs initially in mucosal CD4⁺ T cells, but within days high-level replication occurs in Peyer's patches, the gut lamina propria and mesenteric lymph nodes. Understanding the early events in HIV transmission may provide valuable information relevant to the development of an HIV vaccine. The viral quasispecies in a donor contracts through a genetic bottleneck in the recipient, such that, in low-risk settings, infection is frequently established by a single founder virus. Early-transmitting viruses in subtypes A and C mucosal transmission tend to encode gp120s with reduced numbers of N-linked glycosylation sites at specific positions throughout the V1-V4 domains, relative to typical chronically replicating isolates in the donor quasispecies. The transmission advantage gained by the absence of these N-linked glycosylation sites is unknown. Using primary α₄β₇⁺/CD4⁺ T cells and a flow-cytometry based steady-state binding assay we show that the removal of transmission-associated N-linked glycosylation sites results in large increases in the specific reactivity of gp120 for integrin- α₄β₇. High-affinity for integrin α₄β₇, although not found in many gp120s, was observed in early-transmitting gp120s that we analyzed. Increased α₄β₇ affinity is mediated by sequences encoded in gp120 V1/V2. α₄β₇-reactivity was also influenced by N-linked glycosylation sites located in C3/V4. These results suggest that the genetic bottleneck that occurs after transmission may frequently involve a relative requirement for the productive infection of α₄β₇⁺/CD4⁺ T cells. Early-transmitting gp120s were further distinguished by their dependence on avidity-effects to interact with CD4, suggesting that these gp120s bear unusual structural features not present in many well-characterized gp120s derived from chronically replicating viruses. Understanding the structural features that characterize early-transmitting gp120s may aid in the design of an effective gp120-based subunit vaccine.

Vyšlo v časopise: The Genotype of Early-Transmitting HIV gp120s Promotes αβ –Reactivity, Revealing αβ/CD4 T cells As Key Targets in Mucosal Transmission. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001301
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001301

Souhrn

Zdroje

1. BoilyMC

BaggaleyRF

WangL

MasseB

WhiteRG

2009 Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9 118 129

2. WawerMJ

GrayRH

SewankamboNK

SerwaddaD

LiX

2005 Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191 1403 1409

3. LiQ

DuanL

EstesJD

MaZM

RourkeT

2005 Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434 1148 1152

4. ZhangZQ

WietgrefeSW

LiQ

ShoreMD

DuanL

2004 Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 101 5640 5645

5. LiQ

EstesJD

SchlievertPM

DuanL

BrosnahanAJ

2009 Glycerol monolaurate prevents mucosal SIV transmission. Nature 458 1034 1038

6. VeazeyRS

ShattockRJ

PopeM

KirijanJC

JonesJ

2003 Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 9 343 346

7. ZhangZ

SchulerT

ZupancicM

WietgrefeS

StaskusKA

1999 Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286 1353 1357

8. GuptaP

CollinsKB

RatnerD

WatkinsS

NausGJ

2002 Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J Virol 76 9868 9876

9. HaaseAT

2005 Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 5 783 792

10. AbrahamsMR

AndersonJA

GiorgiEE

SeoigheC

MlisanaK

2009 Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol 83 3556 3567

11. DerdeynCA

DeckerJM

Bibollet-RucheF

MokiliJL

MuldoonM

2004 Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303 2019 2022

12. HaalandRE

HawkinsPA

Salazar-GonzalezJ

JohnsonA

TichacekA

2009 Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog 5 e1000274

13. KearneyM

MaldarelliF

ShaoW

MargolickJB

DaarES

2009 Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J Virol 83 2715 2727

14. KeeleBF

GiorgiEE

Salazar-GonzalezJF

DeckerJM

PhamKT

2008 Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105 7552 7557

15. SagarM

LaeyendeckerO

LeeS

GamielJ

WawerMJ

2009 Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. J Infect Dis 199 580 589

16. LongEM

MartinHLJr

KreissJK

RainwaterSM

LavreysL

2000 Gender differences in HIV-1 diversity at time of infection. Nat Med 6 71 75

17. RitolaK

PilcherCD

FiscusSA

HoffmanNG

NelsonJA

2004 Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol 78 11208 11218

18. SagarM

LavreysL

BaetenJM

RichardsonBA

MandaliyaK

2004 Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. Aids 18 615 619

19. HaaseAT

2010 Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464 217 223

20. HarouseJM

GettieA

EshetuT

TanRC

BohmR

2001 Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol 75 1990 1995

21. HarouseJM

GettieA

TanRC

BlanchardJ

Cheng-MayerC

1999 Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284 816 819

22. ChohanB

LangD

SagarM

KorberB

LavreysL

2005 Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol 79 6528 6531

23. SagarM

WuX

LeeS

OverbaughJ

2006 Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol 80 9586 9598

24. WuX

ParastAB

RichardsonBA

NduatiR

John-StewartG

2006 Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol 80 835 844

25. DerdeynCA

HunterE

2008 Viral characteristics of transmitted HIV. Curr Opin HIV AIDS 3 16 21

26. MoorePL

GrayES

MorrisL

2009 Specificity of the autologous neutralizing antibody response. Curr Opin HIV AIDS 4 358 363

27. MoorePL

RanchobeN

LambsonBE

GrayES

CaveE

2009 Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog 5 e1000598

28. RongR

LiB

LynchRM

HaalandRE

MurphyMK

2009 Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog 5 e1000594

29. ArthosJ

CicalaC

MartinelliE

MacleodK

Van RykD

2008 HIV-1 envelope protein binds to and signals through integrin alpha(4)beta(7), the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9 3 301 9

30. WagnerN

LohlerJ

KunkelEJ

LeyK

LeungE

1996 Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 382 366 370

31. BargatzeRF

JutilaMA

ButcherEC

1995 Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity 3 99 108

32. CicalaC

MartinelliE

McNallyJP

GoodeDJ

GopaulR

2009 The integrin {alpha}4{beta}7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A 106 49 20877 82

33. KellyKA

WileyD

WiesmeierE

BriskinM

ButchA

2009 The Combination of the Gastrointestinal Integrin (alpha4beta7) and Selectin Ligand Enhances T-Cell Migration to the Reproductive Tract During Infection with Chlamydia trachomatis. Am J Reprod Immunol 6 446 452

34. HuangZ

ChouA

TanguayJ

ShenS

MboudjekaI

2008 Levels of N-linked glycosylation on the V1 loop of HIV-1 Env proteins and their relationship to the antigenicity of Env from primary viral isolates. Curr HIV Res 6 296 305

35. Doria-RoseNA

LearnGH

RodrigoAG

NickleDC

LiF

2005 Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope. J Virol 79 11214 11224

36. YehJC

SealsJR

MurphyCI

van HalbeekH

CummingsRD

1993 Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system. Biochemistry 32 11087 11099

37. BinleyJM

BanYE

CrooksET

EgginkD

OsawaK

2010 Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization. J Virol 84 5637 5655

38. StanleyP

NarasimhanS

SiminovitchL

SchachterH

1975 Chinese hamster ovary cells selected for resistance to the cytotoxicity of phytohemagglutinin are deficient in a UDP-N-acetylglucosamine—glycoprotein N-acetylglucosaminyltransferase activity. Proc Natl Acad Sci U S A 72 3323 3327

39. LeeEU

RothJ

PaulsonJC

1989 Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase. J Biol Chem 264 13848 13855

40. ChangVT

CrispinM

AricescuAR

HarveyDJ

NettleshipJE

2007 Glycoprotein structural genomics: solving the glycosylation problem. Structure 15 267 273

41. KrachmarovCP

HonnenWJ

KaymanSC

GornyMK

Zolla-PaznerS

2006 Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. J Virol 80 7127 7135

42. KwongPD

DoyleML

CasperDJ

CicalaC

LeavittSA

2002 HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420 678 682

43. WeiX

DeckerJM

WangS

HuiH

KappesJC

2003 Antibody neutralization and escape by HIV-1. Nature 422 307 312

44. LyA

StamatatosL

2000 V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. J Virol 74 6769 6776

45. KozakSL

PlattEJ

MadaniN

FerroFEJr

PedenK

1997 CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol 71 873 882

46. PinterA

HonnenWJ

HeY

GornyMK

Zolla-PaznerS

2004 The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J Virol 78 5205 5215

47. KotheDL

LiY

DeckerJM

Bibollet-RucheF

ZammitKP

2006 Ancestral and consensus envelope immunogens for HIV-1 subtype C. Virology 352 438 449

48. ArthosJ

CicalaC

SteenbekeTD

ChunTW

Dela CruzC

2002 Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies. J Biol Chem 277 11456 11464

49. BennettA

LiuJ

Van RykD

BlissD

ArthosJ

2007 Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120. J Biol Chem 282 27754 27759

50. ZhouT

XuL

DeyB

HessellAJ

Van RykD

2007 Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445 732 737

51. CenterRJ

EarlPL

LebowitzJ

SchuckP

MossB

2000 The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts. J Virol 74 4448 4455

52. KeeleBF

DerdeynCA

2009 Genetic and antigenic features of the transmitted virus. Curr Opin HIV AIDS 4 352 357

53. MattapallilJJ

DouekDC

HillB

NishimuraY

MartinM

2005 Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 1093 1097

54. HladikF

HopeTJ

2009 HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep 6 20 28

55. LiB

DeckerJM

JohnsonRW

Bibollet-RucheF

WeiX

2006 Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol 80 5211 5218

56. LiuY

CurlinME

DiemK

ZhaoH

GhoshAK

2008 Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology 374 229 233

57. HawkinsRA

RankRG

KellyKA

2000 Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect Immun 68 5587 5594

58. KellyKA

ChanAM

ButchA

DarvilleT

2009 Two Different Homing Pathways Involving Integrin beta7 and E-selectin Significantly Influence Trafficking of CD4 Cells to the Genital Tract Following Chlamydia muridarum Infection. Am J Reprod Immunol 184 885 891

59. KellyKA

NatarajanS

RutherP

WisseA

ChangMH

2001 Chlamydia trachomatis infection induces mucosal addressin cell adhesion molecule-1 and vascular cell adhesion molecule-1, providing an immunologic link between the fallopian tube and other mucosal tissues. J Infect Dis 184 885 891

60. JenkinsN

ParekhRB

JamesDC

1996 Getting the glycosylation right: implications for the biotechnology industry. Nat Biotechnol 14 975 981

61. MarthJD

GrewalPK

2008 Mammalian glycosylation in immunity. Nat Rev Immunol 8 874 887

62. WilleyRL

ShibataR

FreedEO

ChoMW

MartinMA

1996 Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures. J Virol 70 6431 6436

63. DooresKJ

BonomelliC

HarveyDJ

VasiljevicS

DwekRA

2010 Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc Natl Acad Sci U S A 107 13800 13805

64. PinterA

2007 Roles of HIV-1 Env variable regions in viral neutralization and vaccine development. Curr HIV Res 5 542 553

65. Zolla-PaznerS

CardozoT

2010 Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. Nat Rev Immunol 10 527 535

66. HuSL